1 active not recruiting, 1 recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Active not recruiting 1, Recruiting 1 |
Follow pyrotinib: new trials by email Literature Review of pyrotinib trials Research Report on pyrotinib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Real-world Study of Pyrotinib-containing Regimens of Advanced HER2-positive Breast Cancer Pyrotinib, Trastuzumab Rezetecan - HER2 + Breast Cancer, Advanced Breast Cancer | Phase 4 | Recruiting | Peking University People's Hospital | 500 | 2026-07-06 | 2026-07-13 |
| The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC). Pyrotinib, Trastuzumab, Taxanes - HER2-positive Breast Cancer, Advanced Breast Cancer | Phase 4 | Active not recruiting | Hebei Medical University Fourth Hospital | 100 | 2024-01-02 | 2026-11-10 |
Breast Neoplasms (1)
Hebei Medical University Fourth Hospital (1) · Peking University People's Hospital (1)
China (2)